SMTL ID : 4aa0.1

P38ALPHA MAP KINASE BOUND TO CMPD 2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x AA0: N-[4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxidanylidene-quinazolin-3-yl]phenyl]-2-morpholin-4-yl-pyridine-4-carboxamide(Non-covalent)

AA0.1: 21 residues within 4Å: Chain A: V.35, S.37, G.38, V.43, A.56, K.58, E.76, L.79, L.80, M.83, V.88, I.89, L.109, T.111, M.114, I.146, H.153, I.171, L.172, D.173, F.174 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:V.43, A:A.56, A:K.58, A:E.76, A:L.80, A:I.89, A:I.89, A:T.111, A:M.114, A:D.173 Hydrogen bonds: A:K.58, A:E.76, A:E.76, A:T.111, A:M.114, A:D.173 pi-Stacking: A:F.174 pi-Cation interactions: A:F.174

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brown, D.S. et al., The Discovery of N-Cyclopropyl-4-Methyl-3-[6--(4-Methylpiperazin-1-Yl-4-Oxoquinazolin-3(4H)-Yl]Benzamide (Azd6703), a Clinical P38Alpha Map Kinase Inhibitor for the Treatment of Inflammatory Diseases. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-05-16

Peptides

MITOGEN-ACTIVATED PROTEIN KINASE 14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MITOGEN-ACTIVATED PROTEIN KINASE 14

Related Entries With Identical Sequence